SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Intercontinental Exchange entered into a definitive Agreement and Plan of Merger to acquire MarketAxess Holdings Inc. for $167 per share in cash, representing approximately $6.0 billion in equity value and $5.7 billion in total enterprise value. The transaction has been unanimously approved by both boards and is expected to close in the first half of 2027.
View raw filing on EDGAR →Wave Life Sciences announced Q2 2026 financial results via press release, disclosing quarterly revenue of $2.3 million, R&D expenses of $51.3 million, net loss of $69.4 million, cash position of $490.6 million with runway guidance into 3Q 2028, and clinical pipeline updates.
View raw filing on EDGAR →Winchester Bancorp issued a press release on July 30, 2026, reporting fiscal 2026 financial results for the year ended June 30, 2026, including net income of $4.4 million (versus a net loss of $874,000 in the prior year), net interest income of $25.0 million, and per-share earnings of $0.49.
View raw filing on EDGAR →MarketAxess entered into a definitive Agreement and Plan of Merger with Intercontinental Exchange on July 29, 2026, whereby ICE will acquire all outstanding shares of MarketAxess for $167 per share in cash, representing an equity value of approximately $6.0 billion and total enterprise value of approximately $5.7 billion. The transaction has been unanimously approved by both boards and is subject to stockholder approval.
View raw filing on EDGAR →In connection with the pending merger, MarketAxess amended severance and change-of-control arrangements for three named executives: CEO Christopher Concannon, CFO Ilene Fiszel Bieler, and General Counsel Scott Pintoff. The amendments modify the definition of "Good Reason," accelerate vesting of RSUs and PSUs in a change-of-control protection period, and revise severance payment terms.
View raw filing on EDGAR →Saia issued a press release on July 30, 2026 announcing second quarter 2026 financial results, including diluted EPS of $3.51 (vs. $2.67 in Q2 2025), revenue of $956.5 million (17.1% increase), and operating income of $125.2 million (26.0% increase). The press release is attached as Exhibit 99.1 and includes condensed consolidated financial statements and detailed operating metrics. This is a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →This is a press release disclosing BBVA's financial results for the first half of 2026, reporting net attributable profit of €6.05 billion (up 11.1% year-over-year), along with key metrics including ROTE of 22.2%, ROE of 21.1%, and loan growth of 17.7%. The document explicitly states "BBVA Posts Over €6 Billion in Profit for the First Half of 2026" and provides detailed income statement and business segment performance data. Additionally, the release announces a new €2 billion extraordinary share buyback program, which is a material capital allocation decision tied to the strong earnings performance.
View raw filing on EDGAR →MarketAxess issued a press release on July 30, 2026 announcing Q2 2026 financial results, disclosing total revenues of $218.4 million, diluted EPS of $1.93 ($1.95 excluding notable items), and operational metrics across trading channels.
View raw filing on EDGAR →The Board of Directors declared a regular quarterly dividend of $0.78 per share, payable on September 2, 2026 to stockholders of record as of August 19, 2026.
View raw filing on EDGAR →This is a 2Q26 earnings release for BBVA disclosing second-quarter and first-half 2026 financial results. The document presents comprehensive profit & loss statements, key financial metrics (Net Attributable Profit of €3,062M in 2Q26, up 11.4% YoY; EPS of €0.53, up 15.2% YoY), profitability ratios (ROTE 22.2%, ROE 21.1%), and segment performance across Spain, Mexico, Turkey, and South America. This is a material earnings announcement that would affect a reasonable investor's assessment of the registrant's financial performance and position.
View raw filing on EDGAR →Evommune announced initiation of a Phase 2b clinical trial for EVO756, a MRGPRX2 inhibitor in migraine prophylaxis, with top-line data expected in 2027. This is a material operational and clinical development milestone for a clinical-stage biotech company, representing significant progress in its pipeline. While not fitting a specific named event type, this clinical trial initiation is clearly an operational/strategic business event material to investors assessing the company's development progress and commercial prospects.
View raw filing on EDGAR →The filing discloses the appointment of Jennifer O. Kozak to the position of Senior Vice President, Chief Human Resources Officer, effective September 9, 2026, and her addition to the Executive Leadership Team. This is a clear executive appointment of a named officer to a senior leadership role, making it material to investors assessing the company's leadership and organizational capability.
View raw filing on EDGAR →The 6-K announces a notice of redemption for Vodafone's NC5.25 Capital Securities due 2081 at 100% of principal plus accrued interest. While redemption is technically a debt retirement rather than issuance, it represents a material modification of the registrant's direct financial obligations and capital structure. The redemption of a long-dated capital security is a significant financial event affecting the company's debt profile and would be material to investors assessing Vodafone's financial position.
View raw filing on EDGAR →The filing discloses a share repurchase program under which Lite Strategy repurchased approximately 4.9 million shares (13% of outstanding shares) since December 2025, deploying $5.4 million at an average price of $1.11 per share. While the Item 2.02 header suggests financial results, the substantive disclosure centers on a capital return mechanism—a share-repurchase program—which is classified as a form of dividend_distribution. The company explicitly states it intends to continue the program as long as it remains value-accretive, and the press release emphasizes this as a mechanism for "returning value to stockholders." This is material to investors as it reflects capital allocation strategy and affects per-share economics.
View raw filing on EDGAR →This is a standard quarterly earnings release for Q2 2026 ended June 30, 2026. The filing discloses financial results including R&D expenses ($46.9M), SG&A expenses ($18.1M), net loss ($59.5M), and cash position ($717.7M), along with condensed consolidated statements of operations and balance sheets. The press release is furnished as Exhibit 99.1 and Item 2.02 explicitly covers "Results of Operations and Financial Condition," which is the standard Item for earnings announcements.
View raw filing on EDGAR →Erica McLaughlin was elected President and Chief Executive Officer effective October 1, 2026, and elected to the Board of Directors. The appointment follows the retirement of Sean Keohane as CEO and resignation as Director effective September 30, 2026, completing a planned succession transition.
View raw filing on EDGAR →The Company sold 113,268.541 Class I common shares for approximately $2.3 million in an unregistered offering exempt under Section 4(a)(2) and Regulation D/S, representing a material capital raise that increases share count and dilutes existing shareholders.
View raw filing on EDGAR →The Company declared a regular monthly distribution of $0.15 per share for Class I Shares, payable to shareholders of record as of July 27, 2026, with payment on or about August 10, 2026, including distribution reinvestment plan details.
View raw filing on EDGAR →The 6-K body contains POSCO Holdings' Q2 2026 earnings release dated July 30, 2026, disclosing consolidated financial results including revenue (KRW 19.26 trillion), operating profit (KRW 0.82 trillion), and net profit attributable to controlling interest (KRW 0.68 trillion), with detailed segment performance and business activity updates. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →Open Lending Corp completed a merger transaction in which it became an indirect wholly-owned subsidiary of Parent, with all outstanding shares converted into merger consideration and the registrant delisted from Nasdaq. The transaction included Parent's $350 million financing structure ($100M equity + $250M debt) and resulted in material modifications to security holder rights and the registrant's control structure.
View raw filing on EDGAR →The 6-K body discloses provisional Q2 2026 earnings for POSCO HOLDINGS' subsidiary POSCO, including revenue (9.42 trillion KRW), operating profit (0.27 trillion KRW), and net profit (0.06 trillion KRW) with year-over-year and sequential comparisons. Although labeled "provisional" and subject to auditor review, this is a quarterly earnings announcement material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →LSB Industries disclosed Q2 2026 financial results via a presentation made available on July 30, 2026, including net sales of $168M, adjusted EBITDA of $53M (up ~40% YoY), and diluted EPS of $(0.09). The presentation contains detailed financial metrics, operational highlights, and forward-looking guidance on market conditions and capital allocation, consistent with a quarterly earnings disclosure under Item 7.01 (Regulation FD Disclosure).
View raw filing on EDGAR →This exhibit is a comprehensive investor presentation disclosing POSCO Holdings' "Value-Up Plan" — a multi-year strategic transformation initiative covering portfolio evolution (Triple-Core Portfolio: Steel, Lithium+α, Energy), capital allocation targets (KRW 29.1 trillion investment plan through 2028), shareholder return policy (35-40% of adjusted net profit), and financial targets (ROIC 1.9% to 5.8%, PBR 0.4 to 1.0, revenue CAGR 8.4%). While the presentation touches on governance (board communication, treasury share cancellation) and financial strategy (dividend policy, asset restructuring), its primary substance is operational and strategic — the company's business transformation roadmap, overseas expansion, and resource diversification. This is material to investors as it articulates the company's medium-term strategic direction and capital deployment priorities, but does not fit neatly into discrete event categories (not an earnings release, M&A, impairment, or governance action), making `operational_other` the most appropriate classification.
View raw filing on EDGAR →The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A details six separate debt issuances with trade dates of 7/27–7/28/2026, totaling $30 million in principal, with maturities ranging from 2031 to 2041 and coupon rates between 4.5% and 5.94%. This is a classic debt_issuance event under Item 2.03, and the aggregate principal amount and multi-tranche structure make it material to investors assessing the registrant's capital structure and financial obligations.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Linde plc's Annual General Meeting held on July 28, 2026, covering five proposals: election of nine directors, ratification of PWC as independent auditor, approval of auditor remuneration, advisory vote on named executive officer compensation, and treasury share re-allotment authorization. The detailed vote tallies for each proposal are the core content of Item 5.07, which is the designated 8-K item for shareholder vote results. These results are material to investors as they reflect shareholder approval of board composition, auditor selection, and executive compensation governance.
View raw filing on EDGAR →The board of directors elected Tobias B. Moss as a member of the board effective July 28, 2026, to replace departing director Belvin Williamson, Jr. The principal disclosed action is the appointment of a director to the board, making this an exec_appointment event. Board composition changes are material to investors' assessment of governance and oversight.
View raw filing on EDGAR →This is a press release announcing Obsidian Energy's second quarter 2026 financial and operating results, including funds flow from operations of $67.8 million, adjusted funds flow from operations of $73.6 million, net income of $42.0 million, and production of 28,200 boe/d. The document explicitly states "Obsidian Energy Announces Second Quarter 2026 Results" and presents comprehensive financial tables and operational metrics typical of a quarterly earnings announcement.
View raw filing on EDGAR →The filing discloses a declaration of a quarterly dividend of $0.268 per share on outstanding common shares, payable October 26, 2026 to shareholders of record as of September 25, 2026. This is a routine but material capital distribution to shareholders that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →Vodafone completed the acquisition of CK Hutchison Group's 49% stake in VodafoneThree for £4.3 billion, resulting in 100% ownership of the UK's largest mobile operator. This is a material acquisition/change of control transaction funded from existing cash resources, with significant strategic and financial implications including £700 million in expected annual synergies by FY30.
View raw filing on EDGAR →The Board of Directors has authorized a distribution to stockholders across multiple share classes (Class T, D, I, and X-1 common stock) with a record date of July 31, 2026 and payment date of approximately August 5, 2026. This is a clear dividend or distribution declaration to shareholders, which is material to investors as it affects shareholder returns and the company's capital allocation.
View raw filing on EDGAR →First Business Financial Services, Inc. disclosed its Second Quarter 2026 financial results, reporting net income of $15.4 million and diluted EPS of $1.84, along with loan and deposit growth and net interest margin performance metrics. The earnings press release and investor presentation were furnished in connection with the company's earnings call on July 31, 2026.
View raw filing on EDGAR →Tempus AI issued a press release on July 30, 2026 disclosing Q2 2026 financial results, including revenue of $382.5 million (up 22% year-over-year), net income of $5.6 million, and Adjusted EBITDA of $8.0 million, along with raised full-year 2026 revenue guidance of $1.595–$1.605 billion.
View raw filing on EDGAR →Ms. Hiranda S. Donoghue, Executive Vice President and Chief Legal Officer, is departing the Company effective July 31, 2026, following a determination made on July 24, 2026. The disclosure centers on her departure and the interim succession arrangement with Mr. Jack N. Melamed. While the filing also mentions severance benefits under her existing termination agreement, the principal disclosed action is the departure of a named executive officer from a senior role, making this an exec_departure event.
View raw filing on EDGAR →Forrester issued a press release on July 30, 2026 announcing Q2 2026 financial results, including total revenues of $100.2 million (down from $111.7 million in Q2 2025), GAAP net income of $0.78 per diluted share, and adjusted net income of $0.40 per diluted share, along with full-year 2026 guidance.
View raw filing on EDGAR →This is a clear earnings release for Q2 2026 ended June 30, 2026. The press release discloses quarterly financial results including total revenue of $63.3 million, product revenue of $57.4 million (+10% Y/Y), net loss of $2.9 million, and updated 2026 product revenue guidance of $229-$231 million. The filing is properly classified under Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →AnaptysBio disclosed material litigation against Tesaro and GlaxoSmithKline regarding alleged material breach of a Collaboration and Exclusive License Agreement and tortious interference. The filing provides substantive updates on trial completion (July 14-17, 2026) and a court-approved post-trial briefing schedule, indicating this is an ongoing material dispute with significant financial and operational implications for the Company's collaboration arrangements.
View raw filing on EDGAR →ACCO Brands announced its second quarter 2026 financial results on July 30, 2026, with a press release attached as Exhibit 99.1 disclosing net sales of $415.1 million (up 5.1%), diluted EPS of $0.15, adjusted diluted EPS of $0.29, and raised full-year 2026 sales and adjusted EPS outlook. This is a standard quarterly earnings release filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →Western Union issued a press release on July 30, 2026 disclosing second quarter 2026 financial results, including GAAP revenue of $1.0 billion (down 1%), GAAP EPS of $0.24, and adjusted EPS of $0.31, along with segment performance and updated 2026 full-year guidance. This is a standard quarterly earnings release attached as Exhibit 99.1 to Item 2.02, which is the designated Item for disclosure of results of operations and financial condition.
View raw filing on EDGAR →Universal Display Corporation issued a press release on July 30, 2026 disclosing financial results for the second quarter and first half of 2026, including revenue of $152.2 million (Q2) and $294.4 million (H1), net income of $49.4 million and $85.3 million respectively, and revised 2026 guidance to the lower end of the $630–$670 million range. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for earnings releases. The disclosure includes detailed financial statements and is material to investors assessing the registrant's operational and financial performance.
View raw filing on EDGAR →Fulgent Genetics issued a press release on July 30, 2026 announcing Q2 2026 financial results, disclosing revenue of $85.4 million (20.1% sequential growth), a GAAP loss of $29.5 million, and revised full-year 2026 revenue guidance of $330.0–$340.0 million.
View raw filing on EDGAR →Weyerhaeuser disclosed its second quarter 2026 financial results on July 30, 2026, reporting net earnings of $162 million ($0.23 per diluted share) on net sales of $1.9 billion, with Adjusted EBITDA of $310 million, detailed segment performance, and forward guidance.
View raw filing on EDGAR →This is a clear earnings release disclosing consolidated financial and operating results for Q2 and six months ended June 30, 2026. The Item 2.02 filing includes a press release (Exhibit 99.1) announcing revenue of $30.8 million, net income of $0.5 million, and adjusted EBITDA of $3.4 million for Q2 2026, along with detailed business metrics including AUM of $37.0 billion. The disclosure is material to investors assessing the registrant's financial performance and operational progress.
View raw filing on EDGAR →The filing discloses preliminary fiscal Q3 2026 financial results via press release, including expected revenue range of $7.0–$7.5 million, gross margins of 55–58%, and adjusted EBITDA loss of ($3.0)–($3.3) million. Although preliminary and unaudited, this constitutes an earnings release announcement typical of Item 2.02 disclosures, furnished here under Item 7.01 (Regulation FD Disclosure). The company also announces a conference call for August 13, 2026, to discuss complete financial results.
View raw filing on EDGAR →Dolby Laboratories issued a press release on July 30, 2026 announcing its financial results for the fiscal quarter ended June 26, 2026, including total revenue of $305M, GAAP and non-GAAP net income, and forward guidance for Q4 and full-year fiscal 2026.
View raw filing on EDGAR →Dolby Laboratories declared a cash dividend of $0.36 per share payable on August 19, 2026, and announced a $350 million increase to its stock repurchase authorization.
View raw filing on EDGAR →The Board declared a quarterly cash dividend of $3.9844 per share on the Company's 6.375% Mandatory Convertible Preferred Stock, Series A, payable September 1, 2026. This is a routine but material dividend distribution to preferred shareholders, clearly falling within the dividend_distribution category.
View raw filing on EDGAR →The filing announces the Company's release of second quarter 2026 operating and financial results scheduled for August 6, 2026 before market open, along with a conference call where President & CEO Matt Walker and CFO Robert Velasquez will provide updates on recent initiatives and financial results. This is a standard earnings release announcement, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →The disclosure describes the consummation of a SPAC IPO on July 22, 2026, generating $325 million in gross proceeds and a concurrent $6.875 million private placement. While this is a material capital-raising event affecting the registrant's financial position, it does not fit cleanly into the standard 8-K taxonomy: it is neither a traditional earnings release, M&A activity, debt issuance, nor dilutive equity issuance (the latter typically applies to unregistered sales by operating companies). A SPAC IPO is a foundational event but the taxonomy lacks a dedicated category for it, making "other_material" the most appropriate classification given the domain ambiguity.
View raw filing on EDGAR →Pathfinder Bancorp issued a press release on July 30, 2026 disclosing its second quarter 2026 financial results, including net income of $2.7 million ($0.42 per diluted share), net interest income of $10.5 million, and detailed operational metrics. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1, which is the typical disclosure mechanism for earnings announcements.
View raw filing on EDGAR →Annexon entered into a Loan and Security Agreement with Oxford Finance LLC providing for term loans in an aggregate principal amount of up to $200 million, with an initial $50 million tranche funded on July 30, 2026, and an additional $100 million available upon achievement of certain milestones. The facility carries an interest rate of SOFR + 4.6% (floor 7.60%), matures in 2031–2032 depending on milestones, and is secured by substantially all of the company's assets.
View raw filing on EDGAR →